MEDNAX (MD) Tops Q2 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
Mednax (MD) PT Raised to $37 at BMO Capital
August 10, 2021 9:05 AM EDTBMO Capital analyst Matt Borsch raised the price target on Mednax (NYSE: MD) to $37.00 (from $35.00) while maintaining a Market Perform rating.
The analyst commented, "2Q was very solid with strength fueled by a resurgence of volumes. In fact, current volumes across MD's total... More
